APA (7th ed.) Citation
(2026). Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Therapeutics and Clinical Risk Management.
Chicago Style (17th ed.) Citation
"Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies." Therapeutics and Clinical Risk Management 2026.
MLA (9th ed.) Citation
"Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies." Therapeutics and Clinical Risk Management, 2026.
Warning: These citations may not always be 100% accurate.